Cited by 359Genetic Associations and EpidemiologyDiabetes and associated disordersPancreatic function and diabetes

The DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.

Genome-Wide Association Identifies Nine Common Variants Associated With Fasting Proinsulin Levels and Provides New Insights Into the Pathophysiology of Type 2 Diabetes

Open access
Strawbridge, Rona J., Dupuis, Josée, Prokopenko, Inga, Barker, Adam, Ahlqvist, Emma, Rybin, Denis, Petrie, John R., Travers, Mary E., Bouatia-Naji, Nabila, Dimas, Antigone S., Nica, Alexandra, Wheeler, Eleanor, Chen, Han, Voight, Benjamin F., Taneera, Jalal, Kanoni, Stavroula, Peden, John F., Turrini, Fabiola, Gustafsson, Stefan, Zabena, Carina, Almgren, Peter, Barker, David J.P., Barnes, Daniel, Dennison, Elaine M., Eriksson, Johan G., Eriksson, Per, Eury, Elodie, Folkersen, Lasse, Fox, Caroline S., Frayling, Timothy M., Goel, Anuj, Gu, Harvest F., Horikoshi, Momoko, Isomaa, Bo, Jackson, Anne U., Jameson, Karen A., Kajantie, Eero, Kerr-Conte, Julie, Kuulasmaa, Teemu, Kuusisto, Johanna, Loos, Ruth J.F., Luan, Jian'an, Makrilakis, Konstantinos, Manning, Alisa K., Martínez-Larrad, María Teresa, Narisu, Narisu, Nastase Mannila, Maria, Öhrvik, John, Osmond, Clive, Pascoe, Laura, Payne, Felicity, Sayer, Avan A., Sennblad, Bengt, Silveira, Angela, Stančáková, Alena, Stirrups, Kathy, Swift, Amy J., Syvänen, Ann-Christine, Tuomi, Tiinamaija, van 't Hooft, Ferdinand M., Walker, Mark, Weedon, Michael N., Xie, Weijia, Zethelius, Björn, the DIAGRAM Consortium, the GIANT Consortium, the MuTHER Consortium, the CARDIoGRAM Consortium, the C4D Consortium, Ongen, Halit, Mälarstig, Anders, Hopewell, Jemma C., Saleheen, Danish, Chambers, John, Parish, Sarah, Danesh, John, Kooner, Jaspal, Östenson, Claes-Göran, Lind, Lars, Cooper, Cyrus C., Serrano-Ríos, Manuel, Ferrannini, Ele, Forsen, Tom J., Clarke, Robert, Franzosi, Maria Grazia, Seedorf, Udo, Watkins, Hugh, Froguel, Philippe, Johnson, Paul, Deloukas, Panos, Collins, Francis S., Laakso, Markku, Dermitzakis, Emmanouil T., Boehnke, Michael, McCarthy, Mark I., Wareham, Nicholas J., Groop, Leif, Pattou, François, Gloyn, Anna L., Dedoussis, George V., Lyssenko, Valeriya, Meigs, James B., Barroso, Inês, Watanabe, Richard M., Ingelsson, Erik, Langenberg, Claudia, Hamsten, Anders, Florez, Jose C.·2011·Diabetes

Abstract

OBJECTIVE: Proinsulin is a precursor of mature insulin and C-peptide. Higher circulating proinsulin levels are associated with impaired β-cell function, raised glucose levels, insulin resistance, and type 2 diabetes (T2D). Studies of the insulin processing pathway could provide new insights about T2D pathophysiology. RESEARCH DESIGN AND METHODS: We have conducted a meta-analysis of genome-wide association tests of ∼2.5 million genotyped or imputed single nucleotide polymorphisms (SNPs) and fasting proinsulin levels in 10,701 nondiabetic adults of European ancestry, with follow-up of 23 loci in up to 16,378 individuals, using additive genetic models adjusted for age, sex, fasting insulin, and study-specific covariates. RESULTS: Nine SNPs at eight loci were associated with proinsulin levels (P < 5 × 10−8). Two loci (LARP6 and SGSM2) have not been previously related to metabolic traits, one (MADD) has been associated with fasting glucose, one (PCSK1) has been implicated in obesity, and four (TCF7L2, SLC30A8, VPS13C/C2CD4A/B, and ARAP1, formerly CENTD2) increase T2D risk. The proinsulin-raising allele of ARAP1 was associated with a lower fasting glucose (P = 1.7 × 10−4), improved β-cell function (P = 1.1 × 10−5), and lower risk of T2D (odds ratio 0.88; P = 7.8 × 10−6). Notably, PCSK1 encodes the protein prohormone convertase 1/3, the first enzyme in the insulin processing pathway. A genotype score composed of the nine proinsulin-raising alleles was not associated with coronary disease in two large case-control datasets. CONCLUSIONS: We have identified nine genetic variants associated with fasting proinsulin. Our findings illuminate the biology underlying glucose homeostasis and T2D development in humans and argue against a direct role of proinsulin in coronary artery disease pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/db11-0415

Cites

49 of 49 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG. 1. Manhattan plot of the association P values for fasting proinsulin adjusted for fasting insulin. Directly genotyped and imputed SNPs are plotted with their meta-analysis P values (as −log10 values) as a function of genomic position (NCBI Build 36). The SNPs that achieved genome-wide significance (P < 5 × 10−8) on follow-up are shown in red. Insert: Quantile-quantile (Q-Q) plot for fasting proinsulin adjusted for fasting insulin. The expected null distribution is plotted along the diagonal, the entire distribution of observed P values is plotted in blue, and a distribution that excludes the nine novel findings is plotted in red.
FIG. 1. Manhattan plot of the association P values for fasting proinsulin adjusted for fasting insulin. Directly genotyped and imputed SNPs are plotted with their meta-analysis P values (as −log10 values) as a function of genomic position (NCBI Build 36). The SNPs that achieved genome-wide significance (P < 5 × 10−8) on follow-up are shown in red. Insert: Quantile-quantile (Q-Q) plot for fasting proinsulin adjusted for fasting insulin. The expected null distribution is plotted along the diagonal, the entire distribution of observed P values is plotted in blue, and a distribution that excludes the nine novel findings is plotted in red.CC BY-NC-ND · PubMed Central
FIG. 2. Regional plots of eight genomic regions containing novel genome-wide significant associations. For each region, directly genotyped and imputed SNPs are plotted with their meta-analysis P values (as −log10 values) as a function of genomic position (NCBI Build 36). In each panel, the stage 1 discovery SNP taken forward to stage 2 follow-up is represented by a purple diamond (with global meta-analysis P value), with its stage 1 discovery P value denoted by a red diamond with bolded borders. Estimated recombination rates (taken from HapMap) are plotted to reflect the local LD structure around the associated SNPs and their correlated proxies (according to a white to red scale from r2 = 0 to 1, based on pairwise r2 values from HapMap CEU). Gene annotations were taken from the University of California Santa Cruz genome browser. A: ARAP1 region; B: MADD region; C: PCSK1 region; D: TCF7L2 region; E: VPS13C/C2CD4A/B region; F: SLC30A8 region; G: LARP6 region; H: SGSM2 region.
FIG. 2. Regional plots of eight genomic regions containing novel genome-wide significant associations. For each region, directly genotyped and imputed SNPs are plotted with their meta-analysis P values (as −log10 values) as a function of genomic position (NCBI Build 36). In each panel, the stage 1 discovery SNP taken forward to stage 2 follow-up is represented by a purple diamond (with global meta-analysis P value), with its stage 1 discovery P value denoted by a red diamond with bolded borders. Estimated recombination rates (taken from HapMap) are plotted to reflect the local LD structure around the associated SNPs and their correlated proxies (according to a white to red scale from r2 = 0 to 1, based on pairwise r2 values from HapMap CEU). Gene annotations were taken from the University of California Santa Cruz genome browser. A: ARAP1 region; B: MADD region; C: PCSK1 region; D: TCF7L2 region; E: VPS13C/C2CD4A/B region; F: SLC30A8 region; G: LARP6 region; H: SGSM2 region.CC BY-NC-ND · PubMed Central
FIG. 3. Expression profiles of biologically plausible genes within each associated locus across a range of human tissue types, including islet preparations from three donors. Expression levels determined with respect to the geometric mean of three endogenous control assays. A: ARAP1 region; B: MADD region; C: VPS13C/C2CD4A/B region; D: LARP6 region; E: SGSM2 region. F: Expression levels of genes near the proinsulin-associated variants in human FAC-sorted β-cells. Data are expression means ± SD of the relative expression measured by quantitative PCR obtained from three human nondiabetic donors.
FIG. 3. Expression profiles of biologically plausible genes within each associated locus across a range of human tissue types, including islet preparations from three donors. Expression levels determined with respect to the geometric mean of three endogenous control assays. A: ARAP1 region; B: MADD region; C: VPS13C/C2CD4A/B region; D: LARP6 region; E: SGSM2 region. F: Expression levels of genes near the proinsulin-associated variants in human FAC-sorted β-cells. Data are expression means ± SD of the relative expression measured by quantitative PCR obtained from three human nondiabetic donors.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 50 references

Research works printed but not linked: 2

  1. StataCorp, 2007, Stata Statistical Software: Release 10
  2. Li, 2006, Am J Hum Genet, S79, 2290

Cited by

Sorted by citations

See all 359

Metadata

Authors
Strawbridge, R. J., Dupuis, J., Prokopenko, I., Barker, A., Ahlqvist, E., Rybin, D., Petrie, J. R., Travers, M. E., Bouatia-Naji, N., Dimas, A. S., Nica, A., Wheeler, E., Chen, H., Voight, B. F., Taneera, J., Kanoni, S., Peden, J. F., Turrini, F., Gustafsson, S., Zabena, C., Almgren, P., Barker, D. J. P., Barnes, D., Dennison, E. M., Eriksson, J. G., Eriksson, P., Eury, E., Folkersen, L., Fox, C. S., Frayling, T. M., Goel, A., Gu, H. F., Horikoshi, M., Isomaa, B., Jackson, A. U., Jameson, K. A., Kajantie, E., Kerr-Conte, J., Kuulasmaa, T., Kuusisto, J., Loos, R. J. F., Luan, J., Makrilakis, K., Manning, A. K., Martínez-Larrad, M. T., Narisu, N., Nastase Mannila, M., Öhrvik, J., Osmond, C., Pascoe, L., Payne, F., Sayer, A. A., Sennblad, B., Silveira, A., Stančáková, A., Stirrups, K., Swift, A. J., Syvänen, A.-C., Tuomi, T., van 't Hooft, F. M., Walker, M., Weedon, M. N., Xie, W., Zethelius, B., the DIAGRAM Consortium, the GIANT Consortium, the MuTHER Consortium, the CARDIoGRAM Consortium, the C4D Consortium, Ongen, H., Mälarstig, A., Hopewell, J. C., Saleheen, D., Chambers, J., Parish, S., Danesh, J., Kooner, J., Östenson, C.-G., Lind, L., Cooper, C. C., Serrano-Ríos, M., Ferrannini, E., Forsen, T. J., Clarke, R., Franzosi, M. G., Seedorf, U., Watkins, H., Froguel, P., Johnson, P., Deloukas, P., Collins, F. S., Laakso, M., Dermitzakis, E. T., Boehnke, M., McCarthy, M. I., Wareham, N. J., Groop, L., Pattou, F., Gloyn, A. L., Dedoussis, G. V., Lyssenko, V., Meigs, J. B., Barroso, I., Watanabe, R. M., Ingelsson, E., Langenberg, C., Hamsten, A., & Florez, J. C.
Affiliations
  • Karolinska University Hospital (SE)
  • Boston University (US)
  • Centre for Human Genetics (GB)
  • Addenbrooke's Hospital (GB)
  • Lund University (SE)
  • University of Glasgow (GB)
  • University of Oxford (GB)
  • Université Lille-Nord de France, Lille, France
  • University of Geneva (CH)
  • Wellcome Sanger Institute (GB)
  • Broad Institute (US)
  • University of Verona (IT)
  • Karolinska Institutet (SE)
  • CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain
  • Oregon Health & Science University (US)
  • Southampton General Hospital (GB)
  • University of Helsinki (FI)
  • Centre National de la Recherche Scientifique (FR)
  • Brigham and Women's Hospital (US)
  • University of Exeter (GB)
  • Folkhälsans Forskningscentrum (FI)
  • University of Michigan (US)
  • Inserm (FR)
  • Kuopio University Hospital (FI)
  • Laiko General Hospital of Athens (GR)
  • Hospital Clínico San Carlos (ES)
  • National Institutes of Health (US)
  • Atherosclerosis Research Unit, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital Solna, Stockholm, Sweden
  • Newcastle University (GB)
  • Uppsala University (SE)
  • Folkhälsan Research Centre, Helsinki, Finland
  • University of Cambridge (GB)
  • Ealing Hospital NHS Trust (GB)
  • University of Pisa (IT)
  • Department of General Practice and Primary Health Care, University of Helsinki, Helsinki, Finland
  • Mario Negri Institute for Pharmacological Research (IT)
  • University of Münster (DE)
  • Oxford Centre for Diabetes Endocrinology and Metabolism, University of Oxford, Oxford, U.K.
  • Harokopio University of Athens (GR)
  • Harvard University (US)
  • University of Southern California (US)
  • Program in Medical and Population Genetics, Broad Institute, Cambridge, Massachusetts
Corresponding author
  • Langenberg, Claudia
  • Hamsten, Anders
Venue
Diabetes
Published
2011-09-16
Volume
60
Issue
10
Pages
2624-2634
ISSN
  • 0012-1797 (ISSN-L)
  • 1939-327X
OpenAlex
W2151600164
Cited by
356
References
50
Citations by year
2026: 7 · 2025: 7 · 2024: 12 · 2023: 16 · 2022: 18 · 2021: 23 · 2020: 23 · 2019: 27 · 2018: 27 · 2017: 36 · 2016: 30 · 2015: 30 · 2014: 39 · 2013: 29 · 2012: 31
FWCI
19.95
Type
journal article
Language
en
Open access
Locations
  • Diabetes (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
  • Research Explorer (The University of Manchester) (publishedVersion)
  • VU Research Portal (publishedVersion, other-oa)
  • Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
  • QUT ePrints (Queensland University of Technology) (submittedVersion, cc-by-nc-nd)
  • Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele (submittedVersion, cc-by-nc-nd)
  • Minerva Access (University of Melbourne) (submittedVersion, cc-by-nc-nd)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, other-oa)
  • UWA Profiles and Research Repository (UWA) (submittedVersion, other-oa)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion, other-oa)
  • Leiden Repository (Leiden University) (submittedVersion)
  • CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
  • Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
  • ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
  • eScholarship (California Digital Library) (submittedVersion, cc-by)
  • JuSER (Forschungszentrum Jülich) (submittedVersion)
  • Lund University Publications (Lund University) (submittedVersion)
  • Pure Amsterdam UMC (submittedVersion)
  • Scopus (Elsevier) (submittedVersion)
  • Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, cc-by-nc-nd)
  • Radboud Repository (Radboud University) (submittedVersion)
  • RePub (Erasmus University Rotterdam) (submittedVersion)
  • SERVAL (Université de Lausanne) (submittedVersion)
  • Spiral (Imperial College London) (submittedVersion, cc-by-nc-nd)
  • OPUS (Augsburg University) (submittedVersion)
  • Open Research (University of Surrey) (submittedVersion)
  • Archive ouverte UNIGE (University of Geneva) (submittedVersion, cc-by)
  • STM:n Hallinnonalan avoin julkaisuarkisto (Julkari) (submittedVersion)
  • Apollo (University of Cambridge) (submittedVersion, cc-by)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by-nc-nd)
  • Data Archiving and Networked Services (DANS) (submittedVersion, other-oa)
  • Apollo (cc-by)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Wellcome Trust (083270/Z/07/Z, 077016/Z/05/Z, 090532)
  • National Institute for Health and Care Research (NF-SI-0508-10082)
  • British Heart Foundation (RG/08/014/24067)
  • Novo Nordisk Fonden (#NNF10OC1013354)
  • Medical Research Council (MC_PC_U127592696, MC_PC_U127561128, MRC_MC_UP_A620_1015, G0601966, G0601261, MC_UP_A620_1014, G0700931)
  • National Heart, Lung, and Blood Institute (U01HL054527)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK078616, K24DK080140, DK-062370)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
Keywords
proinsulin, type 2 diabetes, single nucleotide polymorphisms, genetic loci, beta-cell function, fasting blood glucose, insulin resistance, ARAP1, PCSK1, prohormone convertase 1/3, TCF7L2, SLC30A8, VPS13C, MADD, LARP6, coronary artery disease, glucose homeostasis
MeSH terms
Adult, Diabetes Mellitus, Type 2, Fasting, Female, Genotype, Humans, Insulin, Male, Proinsulin, Genetic Variation, Genome, Human, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review